Feng, Song
Heath, Emily
Jefferson, Brett
Joslyn, Cliff
Kvinge, Henry
Mitchell, Hugh D.
Praggastis, Brenda
Eisfeld, Amie J.
Sims, Amy C.
Thackray, Larissa B.
Fan, Shufang
Walters, Kevin B.
Halfmann, Peter J.
Westhoff-Smith, Danielle
Tan, Qing
Menachery, Vineet D.
Sheahan, Timothy P.
Cockrell, Adam S.
Kocher, Jacob F.
Stratton, Kelly G.
Heller, Natalie C.
Bramer, Lisa M.
Diamond, Michael S.
Baric, Ralph S.
Waters, Katrina M.
Kawaoka, Yoshihiro
McDermott, Jason E.
Purvine, Emilie http://orcid.org/0000-0003-2069-5594
Funding for this research was provided by:
National Institute of Allergy and Infectious Diseases (U19AI106772)
Pacific Northwest National Laboratory (73639)
Article History
Received: 1 October 2020
Accepted: 13 May 2021
First Online: 29 May 2021
Declarations
:
: Human lungs were obtained under protocol 03-1396, which was approved by the University of North Carolina at Chapel Hill Biomedical Institutional Review Board, and donors gave informed consent. ‘Omics data collection studies for animal samples performed at UNC Chapel Hill were performed in animal biosafety level 3 facilities and were conducted under protocols approved by the Institutional Animal Care and Use Committee at UNC Chapel Hill (IACUC protocol #16-251) according to guidelines set by the Association for the Assessment and Accreditation of Laboratory Animal Care and the U.S. Department of Agriculture. All animal experiments and procedures performed at UW-Madison were approved by the UW-Madison School of Veterinary Medicine Animal Care and Use Committee under relevant institutional and American Veterinary Association guidelines. West Nile virus work in mice was carried out in strict accordance with the recommendations in the <i>Guide for the Care and Use of Laboratory Animals</i> of the National Institutes of Health. The protocols were approved by the Institutional Animal Care and Use Committee at the Washington University School of Medicine (Assurance number A3381-01).
: Not applicable
: RB has ongoing unrelated collaborations and/or sponsored research agreements with Moderna, VaxArt, Eli Lily, Pfizer, Takeda and Ridgeback Biosciences. MD is a consultant for Inbios, Vir Biotechnology, and Fortressa Biotech and on the Scientific Advisory Boards of Moderna and Immunome. The Diamond laboratory has received unrelated funding support in sponsored research agreements from Moderna, Vir Biotechnology, Kaleido, and Emergent BioSolutions.